WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin BTZ BlackRock outlines new strategic shifts to optimize credit allocation for sustained income growth ATKR Atkore Q1 2026 earnings post 275 percent EPS beat over analyst estimates shares edge 15 percent higher today